Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
200-SEL tablets
090504700BBFSBC
|
Proprietary compound preparation BNF 0905047 | Other selenium preparations | Nutrition and Blood | 5 |
|
AadFer 140mg/5ml oral solution
0901011F0BHAAAI
|
AadFer (fumarate) | Ferrous fumarate | Nutrition and Blood | 5 |
|
Abselen 200microgram tablets
090504700BBFTBC
|
Proprietary compound preparation BNF 0905047 | Other selenium preparations | Nutrition and Blood | 5 |
|
AD Caps softgel capsules
0906011D0BHAAAH
|
AD Caps | Vitamin A | Nutrition and Blood | 5 |
|
Aranesp 130micrograms/0.65ml inj pre-filled syringes
0901030J0BBAVAV
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Aranesp SureClick 40micrograms/0.4ml inj pre-filled pens
0901030J0BBAPAP
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Aymes Actagain 2.0 Fibre Starter Pack liquid
0913011U0BDABAD
|
Aymes Rts 2 kcal/ml m/sk high protein, high energy+fibre | RtS 2 kcal/ml m/sk high protein, high energy+fibre (0913011) | Nutrition and Blood | 5 |
|
Aymes Actasolve Shake Fibre Starter Pack powder
0913011D0BBAAAC
|
Aymes powder 1.6 kcal/ml milkshake with fibre | Powder 1.4 - 1.6 kcal/ml milkshake with fibre (0913011) | Nutrition and Blood | 5 |
|
Cardioace tablets
091000000BBXZBU
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | 5 |
|
ColeDose D3 3,200unit capsules
0906040G0ECACDF
|
ColeDose D3 | Colecalciferol | Nutrition and Blood | 5 |
|
Comfort First powder
0913501A0BDAAAE
|
Comfort powder OTC infant formulae | Powder OTC infant formulae (0913501) | Nutrition and Blood | 5 |
|
Darbepoetin alfa 100micrograms/0.5ml inj pre-filled syringes
0901030J0AAAGAG
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Darbepoetin alfa 500micrograms/1ml inj pf dispos dev
0901030J0AAAMAM
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Ener-G gluten free brown rice bread
0904010H0BVABAA
|
Ener-G (G/F Bread) | Gluten free breads | Nutrition and Blood | 5 |
|
Epoetin zeta 8,000units/0.8ml inj pre-filled syringes
0901030Q0AAAGAG
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | 5 |
|
EveryDay-D 400unit chewable tablets
0906040G0DWAAER
|
EveryDay-D | Colecalciferol | Nutrition and Blood | 5 |
|
Fultium daily D3 400unit capsules
0906040G0BXAFBI
|
Fultium-D3 | Colecalciferol | Nutrition and Blood | 5 |
|
Galfer FA capsules
0901011Q0BBAAAA
|
Galfer F.A. | Iron and folic acid | Nutrition and Blood | 5 |
|
Generic Abidec Multivitamin drops
090607000AABFBF
|
Generic compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | 5 |
|
Generic Berocca effervescent tablets sugar
090602800AACZCZ
|
Generic compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | 5 |
|
Generic Forceval capsules
090607000AAA1A1
|
Generic compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | 5 |
|
Generic Fortisip Compact Protein liquid
0913011W0AAABAB
|
RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | Nutrition and Blood | 5 |
|
Glucosamine sulfate 500mg / Chondroitin sulfate 400mg caps
091200000AAEFEF
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | 5 |
|
Glycine 600mg oral powder sachets
091101000AAFQFQ
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | 5 |
|
Glycine powder (Nutricia)
091101000BBURER
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | 5 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.